US FDA’s Overloaded Advanced Therapies Office Eyes Organizational, Communication Changes

 
• By Sue Sutter
Tree branches
Some of the branches of FDA's Office of Tissues and Advanced Therapies have grown so large they are unmanageable. • Source: Alamy

More from Cell & Gene Therapies

More from Advanced Technologies